change control who

Upload: subirybajar

Post on 15-Feb-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/23/2019 Change Control WHO

    1/62

    Change Control

    Luisa Stoppa

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Naning! the People"s #epu$lic of China %&'() Novem$er ())*

  • 7/23/2019 Change Control WHO

    2/62

  • 7/23/2019 Change Control WHO

    3/62

    , |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Programme

    To introduce the general elements on change control

    To train ou in the guidelines !WH"#$%&' &()*S

    guidelines' +,#$%&-

    To become confident with S"&' forms and records of)hange )ontrol Sstem

    To de.elop our inspection plan on change control

  • 7/23/2019 Change Control WHO

    4/62

    - |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Principles of change control

    /efore a medicinal product can be released' we need:

    the manufacture and qualit control procedure should be

    documented in the form of instructions0

    The materials to be used must be specified0

    The basic conditions required for a reproducible qualit'

    efficac and safet must be defined !i1e1 suitable rooms'

    qualified facilities' trained personnel' .alidatedprocedures' established specifications-

  • 7/23/2019 Change Control WHO

    5/62

    . |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Principles of change control

    /efore the requirements can be implemented' the suitabilit ofequipments*facilities and procedures must be pro.en withqualification * .alidation

    This principle is not onl .alid the first time a medicinal product ismanufactured or the first time a facilit is used or a procedure

    comes into effect

    The principle applies to the whole histor of a medicinal product' aprocedure or a facilit and it is to be guaranteed

    2s each requirement is stated in a document' it is clear that eachchange control for the requirements must also alwas in.ol.e adocumentation control

  • 7/23/2019 Change Control WHO

    6/62

    ( |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Principles of change control

    +ach change to pre.iousl appro.ed requirementsrequires a re.iew and authori3ation to keep the sstem inits original state of pro.en suitabilit

    4ormal change control guarantees that all changes aree.aluated for their effect on product qualit or .alidation

    status

    )hange control minimi3es the risk that changes can ha.eon the qualit or process characteristics

    )hange control programs ha.e become recogni3ed asessential element of the pharmaceutical qualit assurancesstem

    ,he task

    of

    change

    control

  • 7/23/2019 Change Control WHO

    7/62

    / |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Principles of change control

    (n the WH"#$%& guideline glossar there is definition ofthe term change control

    Howe.er' the $%& guideline basicall contains onl fewnotes about the handling of changes

  • 7/23/2019 Change Control WHO

    8/620 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Principles of change control

    (n the 2merican )ode of 4ederal 5egulation )45' the responsibilitfor the .erification and authori3ation of changes is task of the

    qualit control unit

    (n the +, regulations' the responsibilit is assigned to 6ualit ,nit

    2s the change control is considered an essential element of the

    pharmaceutical qualit assurance sstem' it is logical the personresponsible is qualit assurance !62 representati.e' 62 head-

  • 7/23/2019 Change Control WHO

    9/62+ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Principles of change control

    )hange control is not department#specific' rather the taskof the whole compan

    The change control monitors all tpes of changes which

    can influence the process or product qualit and states

    the measures necessar for implementing the change ordecides that a change should not be implemented

  • 7/23/2019 Change Control WHO

    10/62

  • 7/23/2019 Change Control WHO

    11/62'' |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Change control programs

    %an tpes of changes affect se.eral areas at the sametime:

    GMP re-uirements #egulator. re-uirements

    Process securit. /validation0

    Product -ualit. /specifications! approval0

    1ffectiveness 2 safet. /approval0

    Suita$le rooms and e-uipment /-ualification0

    Suita$le personnel /training! e3perience0

  • 7/23/2019 Change Control WHO

    12/62

    '2 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    2 central processing of change procedures' coordinatedb the qualit assurance department' has se.eral

    ad.antages:

    8 there is a common understanding of what a change represents0

    8 the classification schemes used b the staff in.ol.ed to ratechanges are congruent0

    8 the risk connected with the change can be e.aluated in a multi#

    disciplinar manner0

    8 there is uniform documentation and authori3ation procedure

    Change control programs

  • 7/23/2019 Change Control WHO

    13/62

    ', |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    The tpe and scope of a change control program mustcompl with the requirements:

    91 (n the classical $%rele.ant areas the change control

    helpsto maintain the .alidated and established status1

    alidated processes' qualified facilities' material

    specifications can be influenced b changes and

    medicinal products no longer compl with specifications

    Change control programs

  • 7/23/2019 Change Control WHO

    14/62

    '- |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    ;1 Holder of marketing authori3ation must guarantee thatnecessar regulator pre#requisites are met1 )ontract

    manufacturers that do not ha.e their own authori3ation

    must guarantee that the contract gi.er is informed of

    internal changes that could ha.e an influenceon theirapplication documentation !this requires that the contract

    gi.er is included in the change control program of the

    contract manufacturer-

    Change control programs

  • 7/23/2019 Change Control WHO

    15/62

    '. |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

  • 7/23/2019 Change Control WHO

    16/62

    '( |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Change control programs

    %an companies rate the changes requiring control

    14'GMP

  • 7/23/2019 Change Control WHO

    17/62

  • 7/23/2019 Change Control WHO

    18/62

    '0 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Change control programs

    "therclassifications are

    possible

  • 7/23/2019 Change Control WHO

    19/62

    '+ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    (t is not decisi.e which and how man change#classes a compan has rated' but how it is

    guaranteed that changes requiring control are

    recogni3ed as such and implemented according

    to a defined procedure

    Change control programs

  • 7/23/2019 Change Control WHO

    20/62

    2* |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    =ot all changes require a re.alidation

    Change control programs

    56+'GMP

  • 7/23/2019 Change Control WHO

    21/62

    2' |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    (n the &()*S document &( >> !chapter 1@1A- there is a list ofchanges that ma require a re#.alidation:

    Change control programs

  • 7/23/2019 Change Control WHO

    22/62

    22 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    2lso in the WH"#$%& guidelines there is a list of changes thatma require a re#.alidation

    Change control programs

  • 7/23/2019 Change Control WHO

    23/62

    2, |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    WH"#$%& guidelines

    Change control programs

  • 7/23/2019 Change Control WHO

    24/62

    2- |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    &()*S document &(>>

    Change control programs

  • 7/23/2019 Change Control WHO

    25/62

    2. |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    The so called trials cause a problem in change control program1

    Trials are preliminar' temporar changes which can permanentl

    established or re.oked after a trial period

    With trials' there is a risk that these intended temporar changes

    graduall become permanent changes without a formal change

    control procedure being carried out

    How long a trial is retained and whether it is withdrawn after a trial

    phase or be introduce permanentl' should be included in the

    same procedure change control as all other changes

    Change control programs

  • 7/23/2019 Change Control WHO

    26/62

    2( |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Be.iations should not be treated as changes' not e.enwhen de.iations become changes after a failure hasbeen clarified

    Be.iation is an unplanned and undesirable de.iation

    from a requirement0 it occurs spontaneousl

    Be.iations should be dealt with according a procedureabout handling de.iations

    2ll .ariations implemented in emergenc !no planned' nocontrolled' no permanent- are included in de.iations

    Change control programs

  • 7/23/2019 Change Control WHO

    27/62

    2/ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Changes/planned changes0

    Deviations/unplanned changes0

    Su$mission of re-uest

    'description of change

    'rationale1valuation

    'effect on validation status

    'definition of revalidation measures

    Approval

    7mplementation of change

    Closing

    Notification

    'description of deviation

    1valuation

    'effect on product -ualit.

    'definition of corrective actions

    'effect on validation status

    'definition of revalidation measures

    7mplementation of deviation

    Closing

    Change control programs

  • 7/23/2019 Change Control WHO

    28/62

  • 7/23/2019 Change Control WHO

    29/62

    2+ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Change control programs

    P7C2S guideline

  • 7/23/2019 Change Control WHO

    30/62

    ,* |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    2 problem is the issue of which changes the changecontrol team should dealt with

    (t is ob.ious that this team cannot deal with all changes

    in the compan

    2s matter of fact' onl changes requiring control should

    be processed b this team

    Change control programs

  • 7/23/2019 Change Control WHO

    31/62

    ,' |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    4irstl' these are changes rele.ant for the regulatorstatus

    Secondl' the are changes which could ha.e an

    influences on the attributes of a $%rele.ant sstem'

    facilit' equipment' material*product' procedure*process

    The team should also deal with all changes whose grade

    or implementation is unclear or questionable

    Change control programs

  • 7/23/2019 Change Control WHO

    32/62

    ,2 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    How the team members communicate with each other?

    =ot all changes require a meeting

    (n cases which are eas to make a decision about' it can

    be useful traditional paper#based circulation procedures'e#mail agreement or access to (ntranet#based forms

    Change control programs

  • 7/23/2019 Change Control WHO

    33/62

    ,, |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    When a change control program has been introduced'the effecti.eness of the sstem can be re.iewed using

    data which is eas to determine

    Total number of changes request /year

    Number of completed change requests / year

    Change type / department involved

    Duration of procedure: from application to closing

    Number of deviations/year

    Number of internal or external complaints /year

    Number of OOS /year

    Change control programs

  • 7/23/2019 Change Control WHO

    34/62

    ,- |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Change control programs

    14'GMP

  • 7/23/2019 Change Control WHO

    35/62

    ,. |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange control requires a written procedureto establish at leastthe following steps:

    hat type of changes does change control ta!e into account"

    hat are the requirements for urgent changes"

    #or $hich areas does this operating procedure apply"

    ho can suggest changes"

    %o$ are changes requested &forms' method of communication("

    %o$ are changes graded and $ho is responsible for the rating"

    %o$ are the measures for carrying out the change established"

    ho is responsible for the implementation and monitoring of all measures"

    ho is included in the change control team"

    hat are the duties of the change control team"

    %o$ is the change documented &format' content' storage("

    ho is responsible to authori)e changes"

    Documentation

  • 7/23/2019 Change Control WHO

    36/62

    ,( |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange control requires a written procedure to establish at leastthe following steps:

  • 7/23/2019 Change Control WHO

    37/62

    ,/ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange control requires a written procedure to establish at leastthe following steps:

  • 7/23/2019 Change Control WHO

    38/62

    ,0 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    2ll qualit#rele.ant changes should be documented

    2ll actions to be taken' including the need for and e7tent

    of qualification or .alidation' should be described

    The records can be archi.ed in paper form orelectronicall

    When storing documents' raw data and other rele.ant

    documents for change should be kept accessible

    Documentation

  • 7/23/2019 Change Control WHO

    39/62

    ,+ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hanges requiring control are generall documented inthe form of a change request in which the applicant for

    the change proposes the tpe of change' suggests the

    timeframes and measures for carring out the change

    The change control team authori3es or not the change

    The documentation for the change procedure should

    show that the change was e.aluated !risk analsis-

    Documentation

  • 7/23/2019 Change Control WHO

    40/62

    -* |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    56+'GMP

  • 7/23/2019 Change Control WHO

    41/62

    -' |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange controlprocedure

    !e7ample 9-

    Documentation

  • 7/23/2019 Change Control WHO

    42/62

    -2 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange control procedure !e7ample ;' 9*;-

    Documentation

  • 7/23/2019 Change Control WHO

    43/62

  • 7/23/2019 Change Control WHO

    44/62

    -- |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange control procedure includes flow chartof thechange control process and the change request form

    !or change form-

    )hange request formrecords a request for change so

    that each change is documented before it is appro.ed

    The change request form includes the description of

    the change' the benefits' costs' urgenc of the

    change' change impact

    Documentation

  • 7/23/2019 Change Control WHO

    45/62

    -. |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange control procedure: flow chart !e7ample 9-

    Documentation

  • 7/23/2019 Change Control WHO

    46/62

    -( |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange control procedure: flow chart !e7ample ;-

    Change Request

    Submission

    Evaluation of

    Change Impact

    ValidationChangeRequest

    Moreinformation

    required

    ChangeActivities

    Change Closed

    Approval

    ActivitiesCompletion

    ChangeActivities

    Approval

    ActivitiesCompletion

  • 7/23/2019 Change Control WHO

    47/62

    -/ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange control procedure: flow chart !e7ample

  • 7/23/2019 Change Control WHO

    48/62

    -0 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange controlprocedure: flow

    chart !e7ample A-

    Documentation

    CC8 9 change control $oard

  • 7/23/2019 Change Control WHO

    49/62

    -+ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange controlprocedure: flow

    chart for change

    master documents

    !e7ample 9-

  • 7/23/2019 Change Control WHO

    50/62

    .* |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange requestform !e7ample 9'

    9*;-

    Documentation

  • 7/23/2019 Change Control WHO

    51/62

    .' |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange requestform !e7ample 9'

    ;*;-

    Documentation

  • 7/23/2019 Change Control WHO

    52/62

    .2 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange requestform !e7ample ;'

    9*;-

    Documentation

  • 7/23/2019 Change Control WHO

    53/62

    ., |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange requestform !e7ample ;'

    ;*;-

    Documentation

  • 7/23/2019 Change Control WHO

    54/62

    .- |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    )hange requestform !e7ample

  • 7/23/2019 Change Control WHO

    55/62

    .. |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange database:electronic cop

  • 7/23/2019 Change Control WHO

    56/62

    .( |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Documentation

    )hange control logbook

    Change control logboo! &year:********(

    Nb+ ,equestdate

    ,equester /department

    -tem Description .pprovaldate

    .ctions andtime limit

    Closingdate

    age:** of::::

    0. 1anager signature ********* Date:::::::

    f

  • 7/23/2019 Change Control WHO

    57/62

    ./ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    13amples of changes

    )hanges to the cleaning procedure# use of a new cleaning agent

    # change in concentration * .olumes of cleaning agent

    # change in .olumes of rinsing water

    # change of cleaning process parameters

    )hanges to the production equipment

    # changes to the )(& equipment

    # changes to * replacement of equipment parts !difficult to give

    detailed examples as these changes are too diverse-# change of process parameters

    1 l f h

  • 7/23/2019 Change Control WHO

    58/62

    .0 |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    13amples of changes

    )hanges to the product# changes to composition !reformulation with different e7cipients-

    # changes to the manufacturing process !i1e1 transfer of a product-

    )hanges to H2) sstem * unidirectional flow

    )hanges in la#out !i1e1 implementation of a pass#bo7-

    7 ti l

  • 7/23/2019 Change Control WHO

    59/62

    .+ |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    7nspection plan

    To ask for the )hange )ontrol standard operatingprocedure

    To check that all rele.ant steps for change control

    implementation are detailed

    To choose some applications !from the list in the logbook-

    To .erif the applications and all requested documents

    !change request form' in.estigation' request and closing

    date-

    C l i

  • 7/23/2019 Change Control WHO

    60/62

    (* |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    Conclusion

    The old adage sas: the onl thing constant is changeC

    # f d t

  • 7/23/2019 Change Control WHO

    61/62

    (' |

    Manufacture of sterile medicines Advanced workshop for SFDA GMP inspectors

    Nanin!" the People#s $epu%lic of &hina" '()2* Novem%er 2**+

    #eference documents

    WH" $%& guidelines 8 Technical 5eport series n1 D

  • 7/23/2019 Change Control WHO

    62/62

    1orkshop on 13 pre4 alification re4 irements for reprod cti e health medicines

    l;stoppa